Advertisement





Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2004; 44:2307-2314, doi:10.1016/j.jacc.2004.09.037
© 2004 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Feiring, A. J.
Right arrow Articles by Lade, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Feiring, A. J.
Right arrow Articles by Lade, S.

CLINICAL RESEARCH: INTERVENTIONAL CARDIOLOGY

Primary stent-supported angioplasty for treatment of below-knee critical limb ischemia and severe claudication

Early and one-year outcomes

Andrew J. Feiring, MD, FACC, FCSAI*, Amy A. Wesolowski, RN and Susan Lade, RN

Columbia-St. Mary's Medical Center, Milwaukee, Wisconsin

Manuscript received May 25, 2004; revised manuscript received August 26, 2004, accepted September 14, 2004.

* Reprint requests and correspondence: Dr. Andrew J. Feiring, Director Cardiac and Vascular Intervention, Columbia-St. Mary's Medical Center, Suite 208, 2015 East Newport Avenue, Milwaukee, Wisconsin 53211 (Email: afeiring{at}execpc.com).

OBJECTIVES: The objective of this study was an investigation of the safety and efficacy of primary below-knee stent-supported angioplasty (BKSSA) for restoring straight inline arterial flow in patients with critical limb ischemia (CLI) or lifestyle-limiting claudication (LLC).

BACKGROUND: Surgical tibial bypass for CLI and severe LLC is associated with significant morbidity, mortality, and graft failure, whereas percutaneous angioplasty is suboptimal.

METHODS: Below-knee stent-supported angioplasty was attempted in 82 patients (92 limbs) with either CLI (68%) or severe LLC (32%). Patients received daily aspirin, thienopyridine, and glycoprotein IIb/IIIa agents during the procedure. One-month major adverse events (MAEs) were defined as death, myocardial infarction, major unplanned amputation, need for surgical revascularization, or major bleeding. Clinical success was defined as improved resting ankle brachial index by ≥0.10, relief of resting pain, healing of ulceration or amputation, and improvement of claudication.

RESULTS: Mean age of patients was 74 ± 17 years. In 86 limbs, straight inline flow was restored to at least one tibial vessel. Technical success was 94% for de novo lesions and there were no MAEs. Ankle brachial indexes increased for all groups (CLI = 0.32 ± 0.13 to 0.9 ± 0.14 and LLC = 0.65 ± 0.09 to 0.95 ± 0.12; p ≤ 0.0001, pre vs. post). Relief of rest pain and healing of ulcerations and amputations were seen in 96% (47 of 49) of patients with CLI who underwent successful intervention.

CONCLUSIONS: Below-knee stent-supported angioplasty for CLI and LLC improves ankle brachial indexes comparable to tibial bypass, heals amputations and ulcerations, relieves rest pain, and improves ambulation. Because BKSSA is associated with minimal MAE, it may hold promise as an alternative therapy for patients with CLI and LLC.

Abbreviations and Acronyms
  ABI = ankle brachial index
  BKSSA = below-knee stent-supported angioplasty
  CLI = critical limb ischemia
  DES = drug-eluting stent
  LLC = lifestyle-limiting claudication
  MAE = major adverse events
  MI = myocardial infarction
  PTA = percutaneous transluminal angioplasty




This article has been cited by other articles:


Home page
Vasc MedHome page
S. A Arain and C. J White
Endovascular therapy for critical limb ischemia
Vascular Medicine, August 1, 2008; 13(3): 267 - 279.
[Abstract] [PDF]


Home page
J Am Coll CardiolHome page
A. J. Feiring
Footnotes on Critical Limb Ischemia
J. Am. Coll. Cardiol., May 20, 2008; 51(20): 1975 - 1976.
[Full Text] [PDF]


Home page
CirculationHome page
J. H. Rogers and J. R. Laird
Overview of New Technologies for Lower Extremity Revascularization
Circulation, October 30, 2007; 116(18): 2072 - 2085.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
G. Tepe, C. Hopfenzitz, K. Dietz, J. Wiskirchen, S. Heller, K. Ouriel, G. Ziemer, C. D. Claussen, and S. H. Duda
Peripheral Arteries: Treatment with Antibodies of Platelet Receptors and Reteplase for Thrombolysis--APART Trial
Radiology, June 1, 2006; 239(3): 892 - 900.
[Abstract] [Full Text] [PDF]


Home page
INT J LOW EXTREM WOUNDSHome page
B. E. Muhs, P. J. Gagne, T. Maldonado, and P. Sheehan
Minimally Invasive Revascularization Strategies for Chronic Lower Limb Ischemia
International Journal of Lower Extremity Wounds, March 1, 2006; 5(1): 35 - 39.
[Abstract] [PDF]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement